| Primary |
| Addison's Disease |
11.9% |
| Urticaria |
11.9% |
| Hormone Replacement Therapy |
9.5% |
| Multiple Sclerosis |
9.5% |
| Migraine |
7.1% |
| Blood Cholesterol Increased |
4.8% |
| Blood Pressure Abnormal |
4.8% |
| Diabetes Mellitus |
4.8% |
| Muscle Spasms |
4.8% |
| Pruritus |
4.8% |
| Rash |
4.8% |
| Arthralgia |
2.4% |
| Arthritis |
2.4% |
| Arthropathy |
2.4% |
| Back Pain |
2.4% |
| Blood Pressure Management |
2.4% |
| Diabetes Mellitus Non-insulin-dependent |
2.4% |
| Electrolyte Imbalance |
2.4% |
| Hypopituitarism |
2.4% |
| Morton's Neuroma |
2.4% |
|
| Hypersensitivity |
14.8% |
| Drug Ineffective |
11.1% |
| Drug Hypersensitivity |
7.4% |
| Thrombosis |
7.4% |
| Anaphylactic Reaction |
3.7% |
| Angioedema |
3.7% |
| Blood Glucose Increased |
3.7% |
| Csf Protein Increased |
3.7% |
| Drug Effect Delayed |
3.7% |
| Hyperglycaemia |
3.7% |
| No Adverse Event |
3.7% |
| Osteonecrosis |
3.7% |
| Pain |
3.7% |
| Pain In Extremity |
3.7% |
| Periarthritis |
3.7% |
| Peripheral Nerve Injury |
3.7% |
| Pyrexia |
3.7% |
| Rash |
3.7% |
| Uterine Disorder |
3.7% |
| Weight Increased |
3.7% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
23.6% |
| Product Used For Unknown Indication |
11.4% |
| Hypertension |
8.7% |
| Pain |
6.0% |
| Rheumatoid Arthritis |
5.8% |
| Back Pain |
5.1% |
| Drug Use For Unknown Indication |
5.1% |
| Eye Oedema |
3.9% |
| Asthma |
3.7% |
| Palpitations |
3.7% |
| Crohn's Disease |
2.9% |
| Arthralgia |
2.7% |
| Rash |
2.7% |
| Renal Transplant |
2.5% |
| Psoriatic Arthropathy |
2.2% |
| Arthritis |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Antibiotic Therapy |
2.0% |
| Erythema |
2.0% |
| Gastric Disorder |
2.0% |
|
| Drug Ineffective |
12.5% |
| Weight Increased |
11.6% |
| Glioma |
10.7% |
| Drug Hypersensitivity |
8.9% |
| Weight Decreased |
7.1% |
| Blood Glucose Increased |
4.5% |
| Metastasis |
4.5% |
| Septic Shock |
4.5% |
| Vomiting |
4.5% |
| Erythema |
3.6% |
| Somnolence |
3.6% |
| Treatment Related Secondary Malignancy |
3.6% |
| Diabetes Mellitus |
2.7% |
| Headache |
2.7% |
| Myalgia |
2.7% |
| Osteonecrosis |
2.7% |
| Pain |
2.7% |
| Ventricular Extrasystoles |
2.7% |
| Vision Blurred |
2.7% |
| Application Site Reaction |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.3% |
| Rheumatoid Arthritis |
13.5% |
| Osteoporosis |
7.0% |
| Hypertension |
5.0% |
| Pain |
5.0% |
| Crohn's Disease |
4.5% |
| Blood Corticotrophin Decreased |
3.1% |
| Drug Use For Unknown Indication |
2.9% |
| Prophylaxis |
2.9% |
| Primary Hypothyroidism |
2.7% |
| Blood Follicle Stimulating Hormone Decreased |
2.5% |
| Blood Luteinising Hormone Decreased |
2.5% |
| Acth Decreased |
2.4% |
| Asthma |
2.3% |
| Blood Thyroid Stimulating Hormone Decreased |
2.3% |
| Growth Hormone Deficiency |
2.3% |
| Follicle-stimulating Hormone Deficiency |
2.1% |
| Psoriatic Arthropathy |
2.1% |
| Hiv Infection |
1.9% |
| Diabetes Mellitus |
1.7% |
|
| Osteonecrosis Of Jaw |
12.1% |
| Vomiting |
7.4% |
| Pneumonia |
6.4% |
| Drug Ineffective |
6.2% |
| Pain In Extremity |
6.2% |
| Osteonecrosis |
5.9% |
| Pyrexia |
5.9% |
| Pain |
5.7% |
| Weight Increased |
5.7% |
| Weight Decreased |
5.2% |
| Arthropathy |
4.0% |
| Death |
4.0% |
| Dyspnoea |
3.5% |
| Nausea |
3.5% |
| Osteoarthritis |
3.5% |
| Hospitalisation |
3.2% |
| Rheumatoid Arthritis |
3.2% |
| Diarrhoea |
3.0% |
| Fatigue |
3.0% |
| Injection Site Pain |
2.7% |
|
| Interacting |
| Multiple Sclerosis Relapse |
23.1% |
| Breast Cancer |
15.4% |
| Contraception |
7.7% |
| Depression |
7.7% |
| Hypothyroidism |
7.7% |
| Insomnia |
7.7% |
| Intestinal Polyp |
7.7% |
| Multiple Sclerosis |
7.7% |
| Premedication |
7.7% |
| Relapsing-remitting Multiple Sclerosis |
7.7% |
|
| Drug Interaction |
33.3% |
| Prothrombin Time Prolonged |
16.7% |
| Thrombosis |
16.7% |
| Venous Thrombosis Limb |
16.7% |
| Vision Blurred |
16.7% |
|
